Catalytic gene editing technologies like CRISPR-Cas9 rely on catalysts to introduce precise modifications in the genome. These biocatalysts can cut DNA at specific sites, allowing for the correction of genetic mutations that cause diseases. This approach holds promise for treating a wide range of genetic disorders by directly targeting and fixing the underlying genetic defects.
